QTRX - クアンテリックス (Quanterix Corporation)

QTRXのニュース

   Quanterix (QTRX) presents at Barclays Global Healthcare Conference - Slideshow  2023/03/17 18:58:56 Seeking Alpha
The following slide deck was published by Quanterix Corporation in conjunction with this event.
   Quanterix''s Return On Capital Employed Insights  2023/03/09 14:47:38 Benzinga
According to data from Benzinga Pro, during Q4, Quanterix ''s (NASDAQ: QTRX ) reported sales totaled $25.82 million. Despite a 47.01% increase in earnings, the company posted a loss of $18.58 million. Quanterix collected $26.65 million in revenue during Q3, but reported earnings showed a $35.06 million loss. What Is ROCE? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company … Full story available on Benzinga.com
   Quanterix to Participate in Barclays Global Healthcare Conference  2023/03/08 21:30:00 Wallstreet:Online
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:35 p.m., EDT. In addition, the company will also host in-person one-on-one meetings with institutional investors on March 15.
   A stock that deserves closer examination: Quanterix Corporation (QTRX)  2023/03/07 16:24:00 US Post News
A share of Quanterix Corporation (NASDAQ:QTRX) closed at $13.59 per share on Monday, up from $12.12 day before. While Quanterix Corporation has overperformed by 12.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, QTRX fell by -56.87%, with highs and lows ranging from $31.87 to $6.31, […]
   Quanterix Corp. PT Raised to $13 at Canaccord Genuity  2023/03/07 12:39:02 Investing.com
https://www.investing.com/news/pro/quanterix-corp-pt-raised-to-13-at-canaccord-genuity-432SI-3023895
   Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference  2023/01/03 21:00:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the 41st Annual J.P. Morgan Healthcare Conference. Quanterix’s session will take place on Thursday, Jan. 12, 2023, at 12 p.m., PST and will be made available to attendees and the general public. In addition to the session, the company will also be hosting one-on
   Quanterix’s Simoa Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference  2022/12/05 21:36:00 Wallstreet:Online
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa technology has powered important advances in ongoing clinical trials for the treatment of Alzheimer’s disease (AD). The findings were presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference held in San Francisco, CA from
   Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference  2022/12/05 21:36:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances in ongoing clinical trials for the treatment of Alzheimer’s disease (AD). The findings were presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference held in San Francisco, CA from November 29 to December 2, 2022. In a historic moment in the fight
   Was anything positive for Quanterix Corporation (QTRX) stock last session?  2022/11/15 13:54:00 US Post News
In Monday’s session, Quanterix Corporation (NASDAQ:QTRX) marked $12.84 per share, up from $12.68 in the previous session. While Quanterix Corporation has overperformed by 1.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, QTRX fell by -77.37%, with highs and lows ranging from $57.55 to $6.31, whereas […]
   Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum  2022/11/10 21:30:00 Kwhen Finance
   Quanterix’s Simoa Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference  2022/12/05 21:36:00 Wallstreet:Online
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa technology has powered important advances in ongoing clinical trials for the treatment of Alzheimer’s disease (AD). The findings were presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference held in San Francisco, CA from
   Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference  2022/12/05 21:36:00 Business Wire
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances in ongoing clinical trials for the treatment of Alzheimer’s disease (AD). The findings were presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference held in San Francisco, CA from November 29 to December 2, 2022. In a historic moment in the fight
   Was anything positive for Quanterix Corporation (QTRX) stock last session?  2022/11/15 13:54:00 US Post News
In Monday’s session, Quanterix Corporation (NASDAQ:QTRX) marked $12.84 per share, up from $12.68 in the previous session. While Quanterix Corporation has overperformed by 1.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, QTRX fell by -77.37%, with highs and lows ranging from $57.55 to $6.31, whereas […]
   Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum  2022/11/10 21:30:00 Kwhen Finance
   Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum  2022/11/10 21:30:00 Wallstreet:Online
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue and Chief Financial Officer Michael Doyle will present at the CG MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 17, 2022 at 4:30 p.m. EST in Boston, MA. Toloue will also host

calendar